Skip to main content
TipRanks
Go Ultimate75% OFF

Carl Sterritt Insider Profile

4 Followers

Carl Sterritt, Chief Executive Officer at Shield Therapeutics, holds 10.20M shares in Shield Therapeutics (Ticker: GB:STX).

Carl Sterritt's Trading History

STX
Shield Therapeutics
Apr 18, 2019Chief Executive OfficerUninformative Sell1.86K£305.97K
GB:STX
Insider Shares: 10.20M (873.06%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Apr 18, 2019Uninformative Sell£1.86K123,690£2.00――
Sep 24, 2018Informative Buy£30.00K88,235£34.00+421.40%―
Oct 05, 2017Uninformative Sell£8.81K8,814£100.00――
Jun 15, 2017Informative Buy£20.00K13,334£150.00-73.90%―

You May Also Like

Carl Sterritt insider profile FAQ

What is the percentage of profitable transactions made by Carl Sterritt?
The percentage of profitable transactions made by Carl Sterritt is 50%.
What is the average return per transaction made by Carl Sterritt?
The average return per transaction made by Carl Sterritt is 173.70%.
What stocks does Carl Sterritt hold?
Carl Sterritt holds: GB:STX stocks.
What was Carl Sterritt’s latest transaction?
Carl Sterritt’s latest transaction was an Uninformative Sell of 1.86K .
What was Carl Sterritt's most profitable transaction?
Carl Sterritt’s most profitable transaction was an Informative Buy of GB:STX stock on September 24, 2018. The return on the trade was 421.40%.
What is Carl Sterritt's role in Shield Therapeutics?
Carl Sterritt's role in Shield Therapeutics is Chief Executive Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.